PMAC Welcomes Northwestern University and Dr. William Gradishar to the Consortium

The Precision Medicine Action for Cancer (PMAC) is honored to announce that Northwestern University has officially joined our academic consortium, further strengthening our collaborative efforts to revolutionize oncology through precision medicine.

A Legacy of Excellence in Oncology

Northwestern University’s inclusion marks a significant expansion of the PMAC network. As home to one of the nation’s premier cancer research and treatment programs, Northwestern brings a wealth of clinical data and scientific innovation to our multi-institutional database. This partnership enhances our collective ability to analyze complex tumor biology and refine treatment protocols for patients globally.

Leadership Highlight: Dr. William Gradishar

We are equally privileged to welcome Dr. William Gradishar to the PMAC Steering Committee.

Dr. Gradishar is Betsy Bramsen Professor of Breast Oncology in the Department of Medicine at the Northwestern University Feinberg School of Medicine. A world-renowned leader in breast cancer research, he has dedicated his career to developing and testing new therapeutic approaches. His expertise will be invaluable as PMAC continues to focus on its mission to bring personalized medicine to all patients with breast cancer.

Strengthening the Precision Medicine Mission

By bridging the gap between Northwestern’s world-class clinical environment and PMAC’s collaborative research framework, we are one step closer to making precision oncology the universal standard of care.

Welcome to the PMAC mission!